6 studies found for:    baricitinib | Phase 3
Show Display Options
Rank Status Study
1 Recruiting A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA)
Condition: Rheumatoid Arthritis
Interventions: Drug: Baricitinib;   Drug: Placebo
2 Active, not recruiting A Study in Participants With Moderate to Severe Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Baricitinib;   Drug: Methotrexate;   Drug: Placebo;   Drug: Folic Acid
3 Active, not recruiting A Study in Moderate to Severe Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Placebo;   Drug: Adalimumab;   Drug: Baricitinib
4 Recruiting An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Baricitinib;   Drug: Placebo
5 Completed A Moderate to Severe Rheumatoid Arthritis Study
Condition: Rheumatoid Arthritis
Interventions: Drug: Placebo;   Drug: Baricitinib
6 Active, not recruiting A Study in Moderate to Severe Rheumatoid Arthritis Participants
Condition: Rheumatoid Arthritis
Interventions: Drug: Placebo;   Drug: Baricitinib

Indicates status has not been verified in more than two years